A beta-caryophyllene synthase and its use in the preparation of beta-caryophyllene
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
- Filing Date
- 2024-09-06
- Publication Date
- 2026-06-16
AI Technical Summary
Existing technologies make it difficult to efficiently and on a large scale obtain β-caryophyllene. Traditional methods of extraction from plants are limited and chemical synthesis is complex. Microbial cell factory production has potential but has not been fully utilized.
By constructing a high-yield β-caryophyllene-producing Saccharomyces cerevisiae engineered strain, β-caryophyllene synthase was expressed in the engineered strain, and farnesyl pyrophosphate was used as a substrate to produce β-caryophyllene. The strain was then expressed by fusion of ERG20 and AarTPS88 with a flexible linker, and HIF-1, UPC2-1 and tHMGR genes were overexpressed to optimize the MVA pathway and improve metabolic flux.
A high-yield β-caryophyllene engineered strain was successfully obtained, with a shake flask yield of 828.4 mg/L and a β-caryophyllene titer of 15.6 g/L in the fermenter, reaching the highest level currently achieved in yeast.
Smart Images

Figure CN119060994B_ABST